ClinicalTrials.Veeva

Menu

Sedation of Morbidly Obese for Balloon Insertion (SedBaloon)

M

Mansoura University

Status

Unknown

Conditions

Morbid Obesity

Treatments

Drug: Ketamine
Drug: Fentanyl

Study type

Interventional

Funder types

Other

Identifiers

NCT03747094
Sedation for balloon insertion

Details and patient eligibility

About

This prospective study will assess the value of different supplements to orpofol bases anesthesia in morbidly obes e patients scheduled for balloon insertion. Two common drugs will be added to propofol bases anesthesia;Ketamine or fentanyl. Effect on prpofol consumption, post-procedure recovery profile, and patient satisfaction will be the study objectives.

Enrollment

70 estimated patients

Sex

All

Ages

20 to 45 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • morbid obese indicated for gastric balloon insertion

Exclusion criteria

  • Refusal Hypersensitivity to any of the study drugs

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

70 participants in 2 patient groups

Fentanyl group
Active Comparator group
Treatment:
Drug: Fentanyl
Ketamine group
Experimental group
Treatment:
Drug: Ketamine

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems